- Home
- QNST vs LTGO Comparison
QNST vs LTGO Comparison
Compare QNST & LTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNST | LTGO |
|---|---|---|
| Founded | 1999 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 924.9M |
| IPO Year | 2009 | 2026 |
Fundamental Metrics
Financial Performance| Metric | QNST | LTGO |
|---|---|---|
| Price | $19.60 | $14.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $22.80 | ★ $52.25 |
| AVG Volume (30 Days) | ★ 715.5K | 201.0K |
| Earning Date | 11-04-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1650.00 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $282,140,000.00 | N/A |
| Revenue This Year | $15.97 | N/A |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | $13.01 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.29 | $13.26 |
| 52 Week High | $22.29 | $25.93 |
Technical Indicators
Market Signals| Indicator | QNST | LTGO |
|---|---|---|
| Relative Strength Index (RSI) | 68.40 | 42.74 |
| Support Level | $17.54 | $13.50 |
| Resistance Level | $19.08 | $17.67 |
| Average True Range (ATR) | 0.56 | 1.39 |
| MACD | 0.26 | 0.08 |
| Stochastic Oscillator | 99.07 | 29.71 |
Price Performance
Historical ComparisonAbout QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. The company operates as one reportable segment. The company generates majority of revenue from United States. The company's products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and Cloud Control Media.
About LTGO Latigo Biotherapeutics Inc. Common Stock
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.